During the past decade, First Urology PSC conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 21 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 11 clinical trials were completed. i.e. 78.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "First Urology PSC" #1 sponsor was "Pfizer" with 7 trials, followed by "GTx" with 6 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Endo Pharmaceuticals" with 3 trials sponsored and "Veru Inc." with 3 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "First Urology PSC" #1 collaborator was "Astellas Pharma Inc" with 4 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 3 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "First Urology PSC" are "Prostate Cancer" (14 trials), "Bladder Cancer" (5 trials), "Overactive Bladder" (5 trials), "Peyronie's Disease" (3 trials) and "Prostatic Neoplasms" (3 trials). Many other conditions were trialed in "First Urology PSC" in a lesser frequency.

Most popular intervention types in "First Urology PSC" are "Drug" (41 trials), "Biological" (9 trials), "Other" (5 trials), "Device" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Enzalutamide" (4 trials), "AA4500" (3 trials), "Leuprolide" (3 trials) and "Prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "First Urology PSC" are 36 trials for "Male" genders, 16 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "First Urology PSC". undefined are not yet recruiting, 7 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in First Urology PSC, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in First Urology PSC, 4 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".